Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer.

Hui ZhaoXiudong LeiJiangong NiuNing ZhangZhigang DuanMariana Chavez-MacGregorSharon H Giordano

Published in: JCO oncology practice (2021)

Five-year AHT adherence rates are low among female patients with breast cancer with private health insurance. Effective approaches to improve AHT adherence are needed.

Keyphrases

health insurance
affordable care act
early stage
glycemic control
stem cells
adipose tissue
skeletal muscle
mesenchymal stem cells
insulin resistance
weight loss